ClinVar Genomic variation as it relates to human health
NM_000517.6(HBA2):c.379G>A (p.Asp127Asn)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
Pathogenic(3); Uncertain significance(1)
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000517.6(HBA2):c.379G>A (p.Asp127Asn)
Variation ID: 15662 Accession: VCV000015662.19
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 16p13.3 16: 173550 (GRCh38) [ NCBI UCSC ] 16: 223549 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Apr 4, 2013 Aug 11, 2024 May 30, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000517.6:c.379G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000508.1:p.Asp127Asn missense NC_000016.10:g.173550G>A NC_000016.9:g.223549G>A NG_000006.1:g.34413G>A NG_046165.1:g.3289G>A NG_059186.1:g.1900G>A NG_059271.1:g.5704G>A LRG_1225:g.1900G>A LRG_1240:g.5704G>A LRG_1240t1:c.379G>A LRG_1240p1:p.Asp127Asn - Protein change
- D127N
- Other names
-
D126N
- Canonical SPDI
- NC_000016.10:173549:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
The Genome Aggregation Database (gnomAD), exomes 0.00000
Trans-Omics for Precision Medicine (TOPMed) 0.00001
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
HBA2 | - | - |
GRCh38 GRCh37 |
4 | 346 | |
LOC106804612 | - | - | - | GRCh38 | - | 283 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
HEMOGLOBIN TARRANT
|
other (1) |
no assertion criteria provided
|
Mar 28, 2013 | RCV000016948.9 |
Pathogenic (3) |
criteria provided, multiple submitters, no conflicts
|
Oct 10, 2022 | RCV001284150.20 | |
Uncertain significance (1) |
criteria provided, single submitter
|
May 30, 2024 | RCV004689422.1 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Sep 09, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
unknown
|
Quest Diagnostics Nichols Institute San Juan Capistrano
Accession: SCV001469776.3
First in ClinVar: Jan 26, 2021 Last updated: Dec 31, 2022 |
Comment:
The variant found in at least one symptomatic individual. The variant occurs in multiple cases with a lone recessive pathogenic/likely pathogenic variant in the same … (more)
The variant found in at least one symptomatic individual. The variant occurs in multiple cases with a lone recessive pathogenic/likely pathogenic variant in the same gene, and several have a phenotype known to be consistent with disease. The variant has been shown to be damaging to protein function(s) relevant to disease mechanism. The variant predicted to have a damaging effect on the protein. (less)
|
|
Pathogenic
(Oct 10, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Accession: SCV001157598.5
First in ClinVar: Feb 10, 2020 Last updated: Mar 04, 2023 |
Comment:
The Hb Tarrant variant (HBA2: c.379G>A; p.Asp127Asn, also known as Asp126Asn when numbered from the mature protein, rs33933481, HbVar ID: 188) has been described in … (more)
The Hb Tarrant variant (HBA2: c.379G>A; p.Asp127Asn, also known as Asp126Asn when numbered from the mature protein, rs33933481, HbVar ID: 188) has been described in healthy individuals or individuals with mild erythrocytosis as a heterozygote and more severe erythrocytosis as a homozygote (Ibarra 1981, Ip 2016, HbVar database). The aspartate at residue 127 is located at the alpha1-alpha2 interface and forms salt bridges with Arg142 on the opposite dimer (Wajcman 2005). Variants in this region commonly lead to high oxygen affinity and reduced cooperativity (Wajcman 2005), which has been observed for the Hb Tarrant variant (Moo-Penn 1977). This variant is reported in ClinVar (Variation ID: 15662) and is found on a single chromosome in the Genome Aggregation Database, indicating it is not a common polymorphism. Based on available information, this variant is considered to be pathogenic dominant for mild erythrocytosis. References: Link to variant in HbVar database: https://globin.bx.psu.edu/hbvar/hbvar.html Ibarra B et al. Heterozygosity and homozygosity for the high oxygen affinity hemoglobin Tarrant or alpha 126 (H9) Asp replaced by Asn in two Mexican families. Hemoglobin. 1981;5(4):337-48. PMID: 7019159. Ip KL et al. Hb Tarrant (a126(H9)Asp?Asn; HBA2: c.379G?>?A (or HBA1)) in a Chinese Family as a Cause of Familial Erythrocytosis. Hemoglobin. 2016 Aug;40(4):260-3. PMID: 27240426. Moo-Penn WF et al. Hemoglobin Tarrant: alpha126(H9) Asp leads to Asn. A new hemoglobin variant in the alpha1beta1 contact region showing high oxygen affinity and reduced cooperativity. Biochim Biophys Acta. 1977 Feb 22;490(2):443-51. PMID: 13856. Wajcman H et al. Hemoglobins with high oxygen affinity leading to erythrocytosis. New variants and new concepts. Hemoglobin. 2005;29(2):91-106. PMID: 15921161. (less)
|
|
Pathogenic
(Sep 02, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Revvity Omics, Revvity
Accession: SCV002024948.3
First in ClinVar: Nov 29, 2021 Last updated: Feb 04, 2024 |
|
|
Uncertain significance
(May 30, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
not specified
Affected status: unknown
Allele origin:
germline
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Accession: SCV005185390.1
First in ClinVar: Aug 11, 2024 Last updated: Aug 11, 2024 |
Comment:
Variant summary: HBA2 c.379G>A (p.Asp127Asn) results in a conservative amino acid change located in the globin domain (IPR000971) of the encoded protein sequence. Four of … (more)
Variant summary: HBA2 c.379G>A (p.Asp127Asn) results in a conservative amino acid change located in the globin domain (IPR000971) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 248750 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.379G>A has been reported in the literature in five families with several heterozygous individuals who were clinically asymptomatic with mild erythrocytosis on hemoglobin analysis and one homozygous individual whose only hematologic finding was moderate erythrocytosis by hemoglobin analysis (e.g. Schroeder_1982, Moo-Penn_1977, Ibarra_1981, Ip_2016). These report(s) do not provide unequivocal conclusions about association of the variant with Alpha Thalassemia. At least one publication reports that this variant results in increased oxygen affinity and low cooperativity (e.g. Moon-Penn_1977). This variant is also known as HB Tarrant. The following publications have been ascertained in the context of this evaluation (PMID: 7019159, 27240426, 13856, 7092797). ClinVar contains an entry for this variant (Variation ID: 15662). Based on the evidence outlined above, the variant was classified as uncertain significance for alpha thalassemia. (less)
|
|
other
(Mar 28, 2013)
|
no assertion criteria provided
Method: literature only
|
HEMOGLOBIN TARRANT
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000037220.1
First in ClinVar: Apr 04, 2013 Last updated: Apr 04, 2013 |
Comment on evidence:
Perea et al. (1999) provided the molecular characterization of a hemoglobin variant in a Mexican family. Located in the HBA2 gene, an asp126-to-asn amino acid … (more)
Perea et al. (1999) provided the molecular characterization of a hemoglobin variant in a Mexican family. Located in the HBA2 gene, an asp126-to-asn amino acid substitution resulted in a variant with high oxygen affinity. Previously described in 4 families with Mexican ancestors, the variant was known as Hb Tarrant (Moo-Penn et al., 1977). (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Hb Tarrant [α126(H9)Asp→Asn; HBA2: c.379G > A (or HBA1)] in a Chinese Family as a Cause of Familial Erythrocytosis. | Ip KL | Hemoglobin | 2016 | PMID: 27240426 |
The Hb Tarrant [alpha126(H9)Asp-->Asn]] mutation is localized in the alpha2-globin gene. | Perea FJ | Hemoglobin | 1999 | PMID: 10490145 |
Identification of eleven human hemoglobin variants by high-performance liquid chromatography: additional data on functional properties and clinical expression. | Schroeder WA | Biochemical genetics | 1982 | PMID: 7092797 |
Heterozygosity and homozygosity for the high oxygen affinity hemoglobin Tarrant or alpha 126 (H9) Asp replaced by Asn in two Mexican families. | Ibarra B | Hemoglobin | 1981 | PMID: 7019159 |
Hemoglobin Tarrant: alpha126(H9) Asp leads to Asn. A new hemoglobin variant in the alpha1beta1 contact region showing high oxygen affinity and reduced cooperativity. | Moo-Penn WF | Biochimica et biophysica acta | 1977 | PMID: 13856 |
Text-mined citations for rs33933481 ...
HelpRecord last updated Nov 10, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.